| scholarly article | Q13442814 |
| P50 | author | Stephen M. Beverley | Q30505183 |
| Paul M Kaye | Q59697523 | ||
| P2093 | author name string | Harris RA | |
| Graham S | |||
| Garcia MR | |||
| P2860 | cites work | The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides | Q24339477 |
| A sequential model for peptide binding and transport by the transporters associated with antigen processing | Q28236633 | ||
| Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E | Q28589161 | ||
| Functional and ultrastructural evidence for intracellular formation of major histocompatibility complex class II-peptide complexes during antigen processing | Q33702492 | ||
| Assembly, transport, and function of MHC class II molecules | Q34328789 | ||
| Getting the inside out: the transporter associated with antigen processing (TAP) and the presentation of viral antigen | Q34754320 | ||
| An acid protease secreted by transformed cells interferes with antigen processing | Q36218951 | ||
| Separation of subcellular compartments containing distinct functional forms of MHC class II | Q36233913 | ||
| Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo | Q36350448 | ||
| Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization | Q36356200 | ||
| Detection of functional class II-associated antigen: role of a low density endosomal compartment in antigen processing | Q36364817 | ||
| Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis | Q36365348 | ||
| Antigens targeted to the Leishmania phagolysosome are processed for CD4+ T cell recognition. | Q39125342 | ||
| Altered course of visceral leishmaniasis in mice expressing transgenic I-E molecules | Q39125351 | ||
| A modified colorimetric assay of macrophage activation for intracellular cytotoxicity against Leishmania parasites | Q39135299 | ||
| Presentation ofLeishmania donovani promastigotes occurs via a brefeldin A-sensitive pathway | Q39159612 | ||
| Pathways for the processing and presentation of antigens to T cells | Q40509383 | ||
| CD8+ T-cell interactions with Toxoplasma gondii: implications for processing of antigen for class-I-restricted recognition. | Q40708644 | ||
| The involvement of antigen processing in determinant selection by class II MHC and its relationship to immunodominance | Q40780290 | ||
| MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation | Q40807437 | ||
| The biochemistry and cell biology of antigen processing and presentation | Q40898211 | ||
| Leishmania-infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells | Q41147792 | ||
| Antigen presentation by Leishmania mexicana-infected macrophages: activation of helper T cells specific for amastigote cysteine proteinases requires intracellular killing of the parasites. | Q41353556 | ||
| Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum | Q41354524 | ||
| A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules | Q41380874 | ||
| Antigen-processing organelles from DRB1*1101 and DRB1*1104 B cell lines display a differential degradation activity | Q41390416 | ||
| Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain | Q41422715 | ||
| Leishmania major infection in mice primes for specific major histocompatibility complex class I-restricted CD8+ cytotoxic T cell responses | Q41431066 | ||
| Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway. Priming in vitro and in vivo for class I-restricted recognition of soluble antigen | Q41566059 | ||
| Recombinant Leishmania surface glycoprotein GP63 is secreted in the baculovirus expression system as a latent metalloproteinase | Q42069351 | ||
| Structurally distinct genes for the surface protease of Leishmania mexicana are developmentally regulated | Q48139144 | ||
| Phagocytic processing of bacterial antigens for class I MHC presentation to T cells | Q50167043 | ||
| Leishmania mexicana promastigotes induce cytotoxic T lymphocytes in vivo that do not recognize infected macrophages. | Q54664301 | ||
| Class I restricted CTL recognition of a soluble protein delivered by liposomes containing lipophilic polylysines | Q56967728 | ||
| Substrate-dependent pH optima of gp63 purified from seven strains of Leishmania | Q67922334 | ||
| Leishmania mexicana mexicana gp63 is a site-specific neutral endopeptidase | Q68522028 | ||
| Leishmania donovani infection in heterozygous and recombinant H-2 haplotype mice | Q70992143 | ||
| Phagocyte-induced antigen-specific activation of unprimed CD8+ T cells in vitro | Q71696210 | ||
| Antigen presentation by Leishmania mexicana-infected macrophages: activation of helper T cells by a model parasite antigen secreted into the parasitophorous vacuole or expressed on the amastigote surface | Q71930353 | ||
| Substrate specificity of allelic variants of the TAP peptide transporter | Q72641749 | ||
| Leishmania major: association of the differentially expressed gene B protein and the surface lipophosphoglycan as revealed by membrane capping | Q72798354 | ||
| The lysosomal gp63-related protein in Leishmania mexicana amastigotes is a soluble metalloproteinase with an acidic pH optimum | Q72840642 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1005-1013 | |
| P577 | publication date | 1997-04-01 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | Epitope cleavage by Leishmania endopeptidase(s) limits the efficiency of the exogenous pathway of major histocompatibility complex class I-associated antigen presentation | |
| P478 | volume | 27 |
| Q34033582 | Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells |
| Q35927465 | CD8(+) T cells in leishmania infections: friends or foes? |
| Q58779502 | Differential induction of cellular responses by live and dead Leishmania promastigotes in healthy donors |
| Q45920568 | Dissimilar peptidase production by avirulent and virulent promastigotes of Leishmania braziliensis: inference on the parasite proliferation and interaction with macrophages. |
| Q39572606 | Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice. |
| Q48249997 | Expression and Function of the Trypanosoma brucei Major Surface Protease (GP63) Genes |
| Q36903844 | Functional paradox in host-pathogen interaction dictates the fate of parasites |
| Q34093793 | Immune evasive mechanisms contributing to persistent Leishmania donovani infection |
| Q35845442 | Immunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation |
| Q36260945 | Macrophage and Leishmania: an unacceptable coexistence |
| Q33557793 | Major surface protease of trypanosomatids: one size fits all? |
| Q36331367 | Synthetic Peptides as Potential Antigens for Cutaneous Leishmaniosis Diagnosis. |
| Q33797324 | The effect of viruses on the ability to present antigens via the major histocompatibility complex |
| Q35561779 | The major surface protease (MSP or GP63) of Leishmania sp. Biosynthesis, regulation of expression, and function. |
| Q36672756 | The ubiquitous gp63-like metalloprotease from lower trypanosomatids: in the search for a function |
| Q34376021 | Toxoplasma gondii and MHC-restricted antigen presentation: on degradation, transport and modulation |
| Q37081691 | Transgenic Leishmania and the immune response to infection |
| Q37996396 | Secreted virulence factors and immune evasion in visceral leishmaniasis. |
Search more.